Terminal loss of heterozygosity (LOH) occurred without loss of genetic material in acute myeloid leukemia

07-31-2006

According to recent research published in the journal Genes Chromosomes & Cancer, "We performed a whole-genome LOH analysis of 32 cases of acute myeloid leukemia with normal karyotype using high-density single nucleotide polymorphism arrays."

"LOH was found in 20% of cases. We identified two types of LOH: (i) interstitial, characterized by small deletions of genomic DNA (2-8 Mb), and (ii) terminal, involving large (30-90 Mb) telomeric regions," explained T.A. Gorletta and colleagues, Fondazione Istituto FIRC di Oncologia Molecolare.

The researchers concluded, "Surprisingly, terminal LOH occurred without loss of genetic material because of deletion of large chromosome regions and their substitution through the duplication of the corresponding regions from the homologous chromosomes (acquired partial uniparental disomy)."

Gorletta and colleagues published their study in Genes Chromosomes & Cancer (Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype. Genes Chromosomes Cancer, 2005;44(3):334-337).

For additional information, contact P.G. Pelicci, Fondazione Istituto FIRC di Oncologia Molecolare, Via Adamello 16, I-20139 Milan, Italy.

Keywords: Milan, Italy, Acute Myeloid Leukemia, Genetics, Genomics, Oncology, Loss of Heterozygosity, Loss of Genetic Material, Homologous Chromosomes.

This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2006, Pain & Central Nervous System Week via NewsRx.com.



Related Diseases: Acute Myeloid Leukemia (AML)
Related Glossary Terms: AML
 
RECENT NEWS
 
Acute Lymphocytic Leukemia (ALL)
Spicy Pickle(TM) Teams With Leukemia & Lymphoma Society In 'Hike For Discovery' Fundraiser On July 18
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
Cancer drug shows promise against graft vs. host disease
Best and brightest leukemia researchers receive $1-million from Cole Foundation
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
Acute Myeloid Leukemia (AML)
Genome Sequencer FLX System plus NimbleGen Sequence Capture Arrays Help Unravel the Cryptic Genetic Changes in Hematological Malignancies
Early findings show promise as AS1411 AML study proceeds to higher-dose stage
Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia
Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Radiation Therapy for Prostate Cancer Increases Incidence of AML
Amyloidosis
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
STEM CELL TRANSPLANTATION PROCEDURE RESULTS IN LONG-TERM SURVIVAL FOR AMYLOIDOSIS PATIENTS
Neurochem receives approvable letter for eprodisate (KIACTA) for treatment of AA amyloidosis
Neurochem, Inc. (NRMX) Receives Approvable Letter for Eprodisate (KIACTA(TM)) for Treatment of AA Amyloidosis; FDA Asks for More Data
Aplastic Anemia
Blood Stem Cells Originate in the Placenta
Stem Cells from a Person's Own Umbilical Cord Effective Treatment For Life-Threatening Blood Disease, Study Data Show
Alexion's Soliris Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Decision Fails Patients with Transfusion-Dependent Anemia
Chronic Lymphocytic Leukemia (CLL)
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer
Best and brightest leukemia researchers receive $1-million from Cole Foundation
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
New lymphoma therapies targets diverse and difficult cancer
Chronic Myeloid Leukemia (CML)
Activation of LYN kinase is associated with imatinib-resistance in CML patients
CHEMGENEX'S OMACETAXINE DEMONSTRATES ACTIVITY IN CML PATIENTS WHO HAVE FAILED THERAPY WITH MULTIPLE TYROSINE KINASE INHIBITORS
Best and brightest leukemia researchers receive $1-million from Cole Foundation
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
Combination of two novel anti-cancer agents may help fight CML resistant to current therapy
Hodgkin Lymphoma
Spicy Pickle(TM) Teams With Leukemia & Lymphoma Society In 'Hike For Discovery' Fundraiser On July 18
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
Cancer drug shows promise against graft vs. host disease
Hodgkin's lymphoma survivors show higher risk of second cancers
Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer
Multiple Myeloma
Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma
Does a 10-year 10% Continuous Complete Remission Rate for Myeloma Patients Suggest Cure?
Thalidomide Plus Dexamethasone: Improved Primary Myeloma Therapy
Bone Pain Can Be A Sign Of Myeloma - Patients And Doctors Join Forces To Raise Awareness Of Early Myeloma Diagnosis
Lenalidomide raises clot risk in multiple myeloma patients
Myelodysplastic Syndrome (MDS)
Xanthus Presents Updated Xanafide Phase 2 Data Showing Durable Complete Remissions in Secondary AML
Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine (VNP40101M) in Combination with Cytarabine
ZIOPHARM Presents Positive Data From Phase II Study Of Darinaparsin In Advanced Hematological Malignancies At AACR 2008 Annual Meeting
Scoring system identifies MDS patients who have low-risk disease but a poor prognosis
Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia
Non-Hodgkin Lymphoma (NHL)
Spicy Pickle(TM) Teams With Leukemia & Lymphoma Society In 'Hike For Discovery' Fundraiser On July 18
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
Aggressive form of lymphoma on the rise: U.S. study
New treatment approach promising for lymphoma patients in the developing world
Testicular Cancer
Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer
Single Dose of Chemotherapy as Effective as Weeks of Radiation Therapy for Testicular Cancer
Drug avoids radiation for early testicular cancer
Polymorphism Reduces Benefit of Bleomycin in Testicular Cancer
Increased Life Expectancy Seen For Patients With Advanced Colorectal, Ovarian and Testicular Cancer